# OKLAHOMA CITY VA MEDICAL CENTER: Cartilage Microbial Products as Novel Drivers of Knee Osteoarthritis Epigenetic Dysregulation

**Lab Budget Score:** 15/100

| Field | Value |
|---|---|
| Organization | OKLAHOMA CITY VA MEDICAL CENTER |
| Location | OKLAHOMA CITY, OK |
| Project | Cartilage Microbial Products as Novel Drivers of Knee Osteoarthritis Epigenetic Dysregulation |
| Project number | 5I01CX002494-04 |
| Mechanism | I01 |
| Institute | Veterans Affairs |
| Awarded | 2026-09-18 |
| Project period | 2022-10-01 to 2027-03-31 |
| UEI | XDFJSSDJG2M9 |

## Why this score


Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11212750). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.